ACP
VRAY

Acuta Capital Partners’s ViewRay, Inc. VRAY Stock Holding History

Acuta Capital Partners’s Portfolio VRAY Stock Details VRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-120,000
Closed -$1.11M – 86
2017
Q4 		$1.11M Buy
+120,000
New +$961K 0.21% 54

Other funds holding VRAY

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Acuta Capital Partners's VRAY Position: Q3 2019 in Review

Acuta Capital Partners sold out of ViewRay, Inc. (VRAY) in Q3 2019, closing a stake of 842,500 shares — an estimated $7.42M sold.

Acuta Capital Partners first reported a position in VRAY in Q1 2017 and held it in 10 quarters. The position peaked at $17.7M in Q4 2017. 145 funds tracked by Wall St. Rank hold VRAY as of Q3 2019.

  • Acuta Capital Partners reported no remaining ViewRay, Inc. position as of Q3 2019 after selling out during the quarter.
  • Acuta Capital Partners sold 842,500 ViewRay, Inc. shares in Q3 2019, an estimated $7.42M.
  • Acuta Capital Partners first reported a position in ViewRay, Inc. in Q1 2017 and held it in 10 quarters.
  • Acuta Capital Partners's ViewRay, Inc. position peaked at $17.7M in Q4 2017.
  • 145 funds tracked by Wall St. Rank held ViewRay, Inc. as of Q3 2019.

Based on Acuta Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.